Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02803333
What this trial is testing

Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 75
Not applicableUnknownNCT04807114
What this trial is testing

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Who this might be right for
Lung Diseases, InterstitialNSCLCImmunotherapy
Universitaire Ziekenhuizen KU Leuven 70
Not applicableLooking for participantsNCT06627595
What this trial is testing

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

Who this might be right for
MelanomaImmunotoxicity
University Hospital, Montpellier 160
Testing effectiveness (Phase 2)Looking for participantsNCT06712875
What this trial is testing

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Who this might be right for
Low Grade GliomaHigh Grade Glioma
Ann & Robert H Lurie Children's Hospital of Chicago 27
Not applicableStudy completedNCT05450367
What this trial is testing

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

Who this might be right for
Blood Cancer
Assistance Publique - Hôpitaux de Paris 249
Not applicableLooking for participantsNCT07357636
What this trial is testing

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Solid TumorImmune-Related Adverse EventsImmunotherapy Toxicity
Shantou University Medical College 940
Testing effectiveness (Phase 2)Ended earlyNCT04892472
What this trial is testing

EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
NovoCure GmbH 15
Not applicableNot Yet RecruitingNCT07660666
What this trial is testing

Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor

Who this might be right for
Melanoma
OHSU Knight Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Not applicableStudy completedNCT07256184
What this trial is testing

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Who this might be right for
Metastatic Malignant Melanoma
Ankara Etlik City Hospital 232
Testing effectiveness (Phase 2)Looking for participantsNCT03406247
What this trial is testing

Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 140
Not applicableNot Yet RecruitingNCT06737640
What this trial is testing

Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Large-scale testing (Phase 3)Looking for participantsNCT06041477
What this trial is testing

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Who this might be right for
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University 540
Not applicableUnknownNCT04929834
What this trial is testing

Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities

Who this might be right for
Skin ToxicityImmunotoxicity
Jessa Hospital 100
Early research (Phase 1)WithdrawnNCT00002956
What this trial is testing

Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants

Who this might be right for
LeukemiaLymphoma
University of Alabama at Birmingham
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Testing effectiveness (Phase 2)UnknownNCT02227277
What this trial is testing

Reducing Proviral HIV DNA With Interferon-a

Who this might be right for
HIVHIV/AIDS
The Wistar Institute 54
Not applicableStudy completedNCT03229083
What this trial is testing

Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
University of Rochester 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05000710
What this trial is testing

Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy

Who this might be right for
Metastatic or Locally Advanced NSCLC
Sheba Medical Center 29
Next Page